These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2018379

  • 1. The effect of lonidamine alone and in combination with cisplatin on in vitro growth and viability of lung squamous cell carcinoma cell lines.
    Raaphorst GP, Ko D, Feeley MM, Danjoux CE, Maroun J, Evans WK.
    Anticancer Res; 1991; 11(1):41-7. PubMed ID: 2018379
    [Abstract] [Full Text] [Related]

  • 2. The in vitro effects of lonidamine combined with cisplatin in human small cell lung cancer cell lines.
    Ko D, Raaphorst GP, Feeley MM, Danjoux CE, Maroun JA, Evans WK.
    Anticancer Res; 1991; 11(1):235-9. PubMed ID: 1850216
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxicity of lonidamine alone and in combination with other drugs against murine RIF-1 and human HT1080 cells in vitro.
    Ning SC, Hahn GM.
    Cancer Res; 1990 Dec 15; 50(24):7867-70. PubMed ID: 2253227
    [Abstract] [Full Text] [Related]

  • 4. Lonidamine can enhance the cytotoxic effect of cisplatin in human tumour cells and rodent cells.
    Raaphorst GP, Feeley MM, Heller DP, Danjoux CE, Martin L, Maroun JA, De Sanctis AJ.
    Anticancer Res; 1990 Dec 15; 10(4):923-7. PubMed ID: 2382989
    [Abstract] [Full Text] [Related]

  • 5. An adriamycin-resistant subline is more sensitive than the parent human small cell lung cancer cell line to lonidamine.
    Kiura K, Ohnoshi T, Ueoka H, Takigawa N, Tabata M, Segawa Y, Shibayama T, Kimura I.
    Anticancer Drug Des; 1992 Dec 15; 7(6):463-70. PubMed ID: 1337430
    [Abstract] [Full Text] [Related]

  • 6. Potentiation of cisplatin cytotoxicity by lonidamine in primary cultures of human ovarian cancer.
    Orlandi L, Zaffaroni N, Gornati D, Veneroni S, Silvestrini R.
    Anticancer Res; 1994 Dec 15; 14(3A):1161-4. PubMed ID: 8074467
    [Abstract] [Full Text] [Related]

  • 7. Growth inhibition by rhein and lonidamine of human glioma cells in vitro.
    Floridi A, Gentile FP, Bruno T, Castiglione S, Zeuli M, Benassi M.
    Anticancer Res; 1990 Dec 15; 10(6):1633-6. PubMed ID: 2285235
    [Abstract] [Full Text] [Related]

  • 8. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
    Wang-Rodriguez J, Lopez JP, Altuna X, Chu TS, Weisman RA, Ongkeko WM.
    Laryngoscope; 2006 Aug 15; 116(8):1409-16. PubMed ID: 16885745
    [Abstract] [Full Text] [Related]

  • 9. Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines.
    Nishio K, Ishida T, Arioka H, Kurokawa H, Fukuoka K, Nomoto T, Fukumoto H, Yokote H, Saijo N.
    Anticancer Res; 1996 Aug 15; 16(6B):3387-95. PubMed ID: 9042196
    [Abstract] [Full Text] [Related]

  • 10. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
    Tyagi AK, Agarwal C, Chan DC, Agarwal R.
    Oncol Rep; 2004 Feb 15; 11(2):493-9. PubMed ID: 14719089
    [Abstract] [Full Text] [Related]

  • 11. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin.
    Wang MB, Yip HT, Srivatsan ES.
    Laryngoscope; 2001 Jun 15; 111(6):982-8. PubMed ID: 11404608
    [Abstract] [Full Text] [Related]

  • 12. Morphological effects of lonidamine on two human-tumor cell culture lines.
    Szekely JG, Lobreau AU, Delaney S, Raaphorst GP, Feeley M.
    Scanning Microsc; 1989 Jun 15; 3(2):681-91; discussion 691-3. PubMed ID: 2814409
    [Abstract] [Full Text] [Related]

  • 13. [Effects of lonidamine alone or in combination with radiotherapy on survival and metabolism in human and rodent cell lines].
    Latz D, Flentje M, Eble M, Hör A, Wannenmacher M.
    Strahlenther Onkol; 1991 Dec 15; 167(12):716-22. PubMed ID: 1763408
    [Abstract] [Full Text] [Related]

  • 14. Thermal behavior of a human glioma cell line and its response to combinations of hyperthermia and lonidamine.
    Floridi A, Gentile FP, Bruno T, Delpino A, Iacobini C, Paggi MG, Castiglione S, Benassi M.
    Oncol Res; 1993 Dec 15; 5(1):1-10. PubMed ID: 8369571
    [Abstract] [Full Text] [Related]

  • 15. Combined effect of heptaplatin and ionizing radiation on human squamous carcinoma cell lines.
    Ryu MR, Paik SY, Chung SM.
    Mol Cells; 2005 Feb 28; 19(1):143-8. PubMed ID: 15750352
    [Abstract] [Full Text] [Related]

  • 16. Combined gamma-irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin.
    Caney C, Singh G, Lukka H, Rainbow AJ.
    Int J Radiat Biol; 2004 Apr 28; 80(4):291-9. PubMed ID: 15204706
    [Abstract] [Full Text] [Related]

  • 17. The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro.
    Elattar TM, Virji AS.
    Anticancer Res; 2000 Apr 28; 20(3A):1733-8. PubMed ID: 10928101
    [Abstract] [Full Text] [Related]

  • 18. Effects of VM-26 and lonidamine on a B16 melanoma cell line.
    Bellelli A, Bellelli L, Di Palma M, Lorenzon I, Mattioni M, Nista A, Pavese I, Rusconi V, Sezzi ML.
    Anticancer Res; 1990 Apr 28; 10(3):565-77. PubMed ID: 2369079
    [Abstract] [Full Text] [Related]

  • 19. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M, Benzo A, Irrissuto C, Lopez G, Curatella B, Maggi CA, Manzini S, Crea A, Caroli S, Cubadda F, Binaschi M.
    Cancer Chemother Pharmacol; 2008 Sep 28; 62(4):621-9. PubMed ID: 18038274
    [Abstract] [Full Text] [Related]

  • 20. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F, Duivenvoorden WC, Singh G.
    Anticancer Drugs; 2009 Feb 28; 20(2):115-22. PubMed ID: 19209028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.